128 related articles for article (PubMed ID: 11903686)
1. Changes in cellular immunity during chemotherapy for testicular cancer.
Kubota Y; Ohji H; Itoh K; Sasagawa I; Nakada T
Int J Urol; 2001 Nov; 8(11):604-8. PubMed ID: 11903686
[TBL] [Abstract][Full Text] [Related]
2. [Difficulty in evaluation of the effectiveness of BEP chemotherapy in a patient with testicular seminoma].
Ohsugi H; Kinoshita H; Kawa G; Matsuda T
Hinyokika Kiyo; 2013 Jun; 59(6):389-93. PubMed ID: 23827875
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics of peripheral blood CD34-positive cells and the optimum timing for harvesting peripheral blood stem cells during BEP chemotherapy in patients with testicular germ cell tumor].
Hioki T; Ogawa K; Yamada Y; Fumino M; Sugimura Y
Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):14-20. PubMed ID: 10689878
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.
de Wit R; Skoneczna I; Daugaard G; De Santis M; Garin A; Aass N; Witjes AJ; Albers P; White JD; Germa-Lluch JR; Marreaud S; Collette L
J Clin Oncol; 2012 Mar; 30(8):792-9. PubMed ID: 22271474
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
Saxman SB; Nichols CR; Einhorn LH
Chest; 1997 Mar; 111(3):657-60. PubMed ID: 9118704
[TBL] [Abstract][Full Text] [Related]
7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.
Krainer M; Wolf H; Michl I; Wiltschke C; Budinsky A; Kaider A; Kratzik C; Eibl MM; Zielinski CC
Cancer; 1995 Jan; 75(2):539-44. PubMed ID: 7529130
[TBL] [Abstract][Full Text] [Related]
9. [Successful collection of peripheral blood stem cells mobilized by high-dose etoposide for patients with chemotherapy-resistant and/or poor prognostic testicular cancer].
Nakagawa S; Sugimoto K; Mikami K; Watanabe H; Sonoda Y; Kuzuyama Y; Abe T; Fujii H
Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):571-8. PubMed ID: 7514697
[TBL] [Abstract][Full Text] [Related]
10. [BEP (bleomycin, etoposide, cisplatinum) chemotherapy as an induction therapy of advanced extragonadal germ cell tumor].
Goto S; Fukui I; Ando M; Kihara K; Kitahara S; Tsujii T; Noro A; Hagiwara T; Toyoshima T; Tsukamoto T
Hinyokika Kiyo; 1991 Dec; 37(12):1689-93. PubMed ID: 1723842
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
[TBL] [Abstract][Full Text] [Related]
12. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
13. [Effective administration of recombinant granulocyte colony-stimulating factor to prevent granulocytopenia due to combination chemotherapy for testicular germ cell tumors].
Nonomura K; Shinohara N; Shinno Y; Seki T; Koyanagi T; Nagamori S; Fujieda J; Togashi M; Ohashi N; Abe N; Toyota K; Maru A; Gotoh T; Sakakibara N; Sakashita S; Kosugi M; Adachi Y
Hinyokika Kiyo; 1996 Sep; 42(9):699-704. PubMed ID: 8918674
[TBL] [Abstract][Full Text] [Related]
14. [Secondary leukemia following ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer].
Matsumoto S; Matsuda H; Uejima S; Kurita T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):687-91. PubMed ID: 11109821
[TBL] [Abstract][Full Text] [Related]
15. Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.
Krainer M; Wolf HM; Wiltschke C; Wilfing A; Kaider A; Kratzik C; Eibl MM; Zielinski CC
Urology; 2000 Jun; 55(6):934-8. PubMed ID: 10840113
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
[TBL] [Abstract][Full Text] [Related]
17. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
Cheng E; Berthold DR; Moore MJ; Duran I
Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
[No Abstract] [Full Text] [Related]
18. [Treatment of metastatic seminoma by chemotherapy.: an experience].
Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
[TBL] [Abstract][Full Text] [Related]
19. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L
J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
